Study of GST-HG171/Ritonavir Compared With Placebo in Patients With Mild to Moderate COVID-19
Clinical trial NCT05656443 · COMPLETED
Trial details
- NCT number
- NCT05656443
- Sponsor
- Fujian Akeylink Biotechnology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-19
- Primary completion
- 2023-05-31
- Enrollment
- 1246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.